Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
7.59
+0.05 (0.66%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Ginkgo Bioworks Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 227.04 | 251.46 | 477.71 | 313.84 | 76.66 | Upgrade
|
| Revenue Growth (YoY) | -9.71% | -47.36% | 52.22% | 309.40% | 41.48% | Upgrade
|
| Cost of Revenue | 44.55 | 54.01 | 204.22 | 129.69 | 15.61 | Upgrade
|
| Gross Profit | 182.5 | 197.45 | 273.49 | 184.15 | 61.05 | Upgrade
|
| Selling, General & Admin | 237.15 | 350.66 | 1,403 | 862.95 | 38.31 | Upgrade
|
| Research & Development | 424.06 | 580.62 | 1,053 | 1,150 | 159.77 | Upgrade
|
| Operating Expenses | 661.21 | 931.28 | 2,456 | 2,013 | 198.07 | Upgrade
|
| Operating Income | -478.72 | -733.83 | -2,182 | -1,828 | -137.03 | Upgrade
|
| Interest Expense | -0.09 | -0.09 | -0.11 | -2.37 | -2.39 | Upgrade
|
| Interest & Investment Income | 38.61 | 57.22 | 20.26 | 0.84 | 2.58 | Upgrade
|
| Earnings From Equity Investments | - | -2.64 | -43.76 | -77.28 | -0.4 | Upgrade
|
| Other Non Operating Income (Expenses) | 9.57 | 14.31 | 132.6 | 56.88 | 7.84 | Upgrade
|
| EBT Excluding Unusual Items | -430.63 | -665.04 | -2,073 | -1,850 | -129.39 | Upgrade
|
| Merger & Restructuring Charges | -24.17 | -96.21 | -27.9 | - | - | Upgrade
|
| Impairment of Goodwill | -47.86 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -28.83 | -54.83 | -53.34 | -11.54 | -3.73 | Upgrade
|
| Gain (Loss) on Sale of Assets | -7.01 | -42.5 | 31.89 | - | - | Upgrade
|
| Asset Writedown | -5.8 | -25.19 | - | - | - | Upgrade
|
| Other Unusual Items | -3.21 | -9.17 | 1.26 | 23.83 | 8.29 | Upgrade
|
| Pretax Income | -547.51 | -892.94 | -2,121 | -1,838 | -124.83 | Upgrade
|
| Income Tax Expense | -0.48 | -0.07 | -15.03 | -1.48 | 1.89 | Upgrade
|
| Earnings From Continuing Operations | -547.03 | -892.87 | -2,106 | -1,837 | -126.72 | Upgrade
|
| Minority Interest in Earnings | - | - | 1.44 | 6.6 | 0.11 | Upgrade
|
| Net Income | -547.03 | -892.87 | -2,105 | -1,830 | -126.61 | Upgrade
|
| Net Income to Common | -547.03 | -892.87 | -2,105 | -1,830 | -126.61 | Upgrade
|
| Shares Outstanding (Basic) | 52 | 49 | 42 | 34 | 32 | Upgrade
|
| Shares Outstanding (Diluted) | 52 | 49 | 42 | 34 | 32 | Upgrade
|
| Shares Change (YoY) | 6.76% | 15.75% | 23.48% | 6.71% | 10.95% | Upgrade
|
| EPS (Basic) | -10.54 | -18.37 | -50.15 | -53.83 | -3.97 | Upgrade
|
| EPS (Diluted) | -10.54 | -18.37 | -50.20 | -55.53 | -4.00 | Upgrade
|
| Free Cash Flow | -382.13 | -336.3 | -304.47 | -310.34 | -193.65 | Upgrade
|
| Free Cash Flow Per Share | -7.36 | -6.92 | -7.25 | -9.13 | -6.08 | Upgrade
|
| Gross Margin | 80.38% | 78.52% | 57.25% | 58.68% | 79.64% | Upgrade
|
| Operating Margin | -210.85% | -291.84% | -456.83% | -582.62% | -178.75% | Upgrade
|
| Profit Margin | -240.94% | -355.08% | -440.63% | -583.12% | -165.16% | Upgrade
|
| Free Cash Flow Margin | -168.31% | -133.74% | -63.74% | -98.89% | -252.62% | Upgrade
|
| EBITDA | -415.7 | -663.33 | -2,140 | -1,799 | -123.16 | Upgrade
|
| EBITDA Margin | -183.09% | -263.80% | - | - | -160.67% | Upgrade
|
| D&A For EBITDA | 63.02 | 70.51 | 42.55 | 29.08 | 13.86 | Upgrade
|
| EBIT | -478.72 | -733.83 | -2,182 | -1,828 | -137.03 | Upgrade
|
| EBIT Margin | -210.85% | -291.84% | - | - | -178.75% | Upgrade
|
| Revenue as Reported | 227.04 | 251.46 | 477.71 | 313.84 | 76.66 | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.